https://pubmed.ncbi.nlm.nih.gov/38116086
A boy with growth and language development delay was diagnosed with Floating-Harbor syndrome through genetic testing, and his condition improved with growth hormone therapy and language rehabilitation.
https://pubmed.ncbi.nlm.nih.gov/38116086
A boy with growth and language development delay was diagnosed with Floating-Harbor syndrome through genetic testing, and his condition improved with growth hormone therapy and language rehabilitation.
https://pubmed.ncbi.nlm.nih.gov/38116085
The Chaga mushroom, a versatile and understudied fungus, contains various bioactive compounds with potential uses in pharmaceuticals, agriculture, food, and cosmetics, including antioxidant, anti-inflammatory, antiviral, and antitumor properties, as well as traditional uses for medicinal and cultural practices.
https://pubmed.ncbi.nlm.nih.gov/38116084
Empagliflozin, an SGLT2 inhibitor, protects against palmitate-induced cardiomyocyte injury by improving insulin sensitivity, reducing ER stress, inflammation, and apoptosis, and enhancing fatty acid oxidation via AMPK pathway activation.
https://pubmed.ncbi.nlm.nih.gov/38116081
Salvia miltiorrhiza, a Chinese medicine with cardiovascular benefits, shows promising potential in treating various musculoskeletal diseases, such as osteoporosis, fractures, and arthritis, due to its active ingredients’ regulation of different signaling pathways.
https://pubmed.ncbi.nlm.nih.gov/38116080
The abstract reports a study finding that the extract of Nyctanthes arbor-tristis (NAT) shows potential as a therapeutic option for treating rheumatoid arthritis, as it demonstrated anti-inflammatory effects in a rat model of the disease.
https://pubmed.ncbi.nlm.nih.gov/38116079
This study establishes a method to determine the distribution of five markers from the antitumor compound preparation Qidongning Formula in rat tissues, providing a quality control foundation for its clinical application.
https://pubmed.ncbi.nlm.nih.gov/38116078
Variable new antigen receptors (vNARs) show potential as a novel strategy to inhibit the activity of cathepsin S (CTSS), a protease implicated in various pathologies, by preventing its activation to the mature enzyme and impeding cell invasion.
https://pubmed.ncbi.nlm.nih.gov/38116077
This study found that anticoagulation therapy in inpatients with nonvalvular atrial fibrillation is often inappropriate, with underdosing and non-use being common issues, and recommends tailored anticoagulation regimens to suit each patient’s needs.